{"id":69605,"date":"2026-07-08T14:33:44","date_gmt":"2026-07-08T06:33:44","guid":{"rendered":"https:\/\/flcube.com\/?p=69605"},"modified":"2026-07-08T14:33:45","modified_gmt":"2026-07-08T06:33:45","slug":"otr-therapeutics-partners-with-lg-chem-to-accelerate-early-stage-oncology-programs-with-china-global-development-model","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=69605","title":{"rendered":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>OTR Therapeutics<\/strong> announced a <strong>strategic collaboration<\/strong> with <strong>LG Chem<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/051910:KRX\">KRX: 051910<\/a>) to jointly accelerate the discovery, evaluation, and development of <strong>early-stage innovative oncology programs<\/strong>. The partnership leverages OTR&#8217;s <strong>China-based R&amp;D advantages<\/strong> and <strong>local life sciences network<\/strong> for early development, while LG Chem will lead <strong>global clinical development and commercialization<\/strong> outside China.<\/p>\n\n\n\n<h2 id=\"h-collaboration-framework-amp-geographic-responsibilities\" class=\"wp-block-heading\">Collaboration Framework &amp; Geographic Responsibilities<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>OTR Therapeutics \/ LG Chem<\/td><\/tr><tr><td><strong>Therapeutic Focus<\/strong><\/td><td>Early-stage innovative oncology programs<\/td><\/tr><tr><td><strong>OTR Responsibilities<\/strong><\/td><td>Program identification, technical assessment, preclinical and early clinical development (China)<\/td><\/tr><tr><td><strong>LG Chem Responsibilities<\/strong><\/td><td>Global clinical development, regulatory strategy, commercialization (ex-China)<\/td><\/tr><tr><td><strong>Geographic Model<\/strong><\/td><td>China-focused early development + Global late-stage development<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>8 July 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-value-proposition-amp-operational-structure\" class=\"wp-block-heading\">Strategic Value Proposition &amp; Operational Structure<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Program Sourcing<\/strong>: OTR will leverage its <strong>extensive network of partnerships<\/strong> in China&#8217;s life sciences sector and <strong>business development capabilities<\/strong> to identify promising early-stage oncology assets from academic institutions, biotech companies, and research organizations.<\/li>\n\n\n\n<li><strong>China R&amp;D Advantages<\/strong>: OTR will capitalize on <strong>China&#8217;s comprehensive advantages<\/strong> in R&amp;D efficiency, scientific expertise, and cost-effectiveness to conduct rapid preclinical optimization and Phase I\/II clinical studies, potentially compressing traditional development timelines by 30-50%.<\/li>\n\n\n\n<li><strong>Global Development Pathway<\/strong>: Successful programs will transition to LG Chem&#8217;s global development infrastructure for Phase III trials, regulatory submissions, and commercial launch across international markets, creating a seamless China-to-global development continuum.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The collaboration represents an innovative <strong>&#8220;China discovery, global development&#8221;<\/strong> model that addresses key challenges in oncology drug development: high costs, long timelines, and complex global regulatory requirements.<\/p>\n\n\n\n<h2 id=\"h-financial-terms-amp-commercial-rights\" class=\"wp-block-heading\">Financial Terms &amp; Commercial Rights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Upfront Payments<\/strong>: OTR receives initial collaboration payments to support program identification and early development activities<\/li>\n\n\n\n<li><strong>Milestone Payments<\/strong>: Additional payments tied to global clinical development and regulatory achievements for jointly in-licensed programs<\/li>\n\n\n\n<li><strong>Opt-in Rights<\/strong>: OTR retains the right to <strong>opt into global development<\/strong> and obtain <strong>partial global rights<\/strong> to successful products, providing upside participation beyond China<\/li>\n\n\n\n<li><strong>Revenue Sharing<\/strong>: Commercial terms for China market not disclosed, but likely structured to provide OTR with significant local commercial rights<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-context-amp-strategic-implications\" class=\"wp-block-heading\">Market Context &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Biotech Ecosystem<\/strong>: The partnership capitalizes on China&#8217;s maturing biotechnology ecosystem, which has produced numerous innovative oncology assets but often lacks global development and commercialization capabilities.<\/li>\n\n\n\n<li><strong>LG Chem&#8217;s Global Ambitions<\/strong>: The collaboration supports LG Chem&#8217;s strategic expansion in pharmaceuticals, leveraging external innovation to build a robust oncology pipeline without significant internal discovery investment.<\/li>\n\n\n\n<li><strong>Risk-Sharing Model<\/strong>: The geographic division of responsibilities creates an efficient risk-sharing structure where each party focuses on their core competencies\u2014OTR on rapid, cost-effective early development and LG Chem on complex global late-stage execution.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking information regarding strategic collaborations, development models, and financial arrangements. Actual results may differ due to program selection outcomes, clinical trial results, regulatory decisions, and market conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1],"tags":[4851,562,4490],"class_list":["post-69605","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-krx-051910","tag-lg-chem","tag-otr-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR&#039;s China-based R&amp;D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=69605\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model\" \/>\n<meta property=\"og:description\" content=\"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR&#039;s China-based R&amp;D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=69605\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-08T06:33:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-08T06:33:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model\",\"datePublished\":\"2026-07-08T06:33:44+00:00\",\"dateModified\":\"2026-07-08T06:33:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605\"},\"wordCount\":470,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"KRX: 051910\",\"LG Chem\",\"OTR Therapeutics\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69605#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=69605\",\"name\":\"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-07-08T06:33:44+00:00\",\"dateModified\":\"2026-07-08T06:33:45+00:00\",\"description\":\"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR's China-based R&D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69605\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69605#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model - Insight, China&#039;s Pharmaceutical Industry","description":"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR's China-based R&D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=69605","og_locale":"en_US","og_type":"article","og_title":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model","og_description":"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR's China-based R&D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.","og_url":"https:\/\/flcube.com\/?p=69605","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-08T06:33:44+00:00","article_modified_time":"2026-07-08T06:33:45+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=69605#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=69605"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model","datePublished":"2026-07-08T06:33:44+00:00","dateModified":"2026-07-08T06:33:45+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=69605"},"wordCount":470,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["KRX: 051910","LG Chem","OTR Therapeutics"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=69605#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=69605","url":"https:\/\/flcube.com\/?p=69605","name":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-07-08T06:33:44+00:00","dateModified":"2026-07-08T06:33:45+00:00","description":"OTR Therapeutics announced a strategic collaboration with LG Chem (KRX: 051910) to jointly accelerate the discovery, evaluation, and development of early-stage innovative oncology programs. The partnership leverages OTR's China-based R&D advantages and local life sciences network for early development, while LG Chem will lead global clinical development and commercialization outside China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=69605#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=69605"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=69605#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"OTR Therapeutics Partners with LG Chem to Accelerate Early-Stage Oncology Programs with China-Global Development Model"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69605"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69605\/revisions"}],"predecessor-version":[{"id":69607,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69605\/revisions\/69607"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}